No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /

No. 301 - 400 Paclitaxel Patents:

	PAT. NO		Title
301	6,372,738		Cytotoxic agents comprising taxanes and their therapeutic use
302	6,372,726		Methods of cancer treatment using NAALADase inhibitors
303	6,372,719		.alpha..nu..beta.3 integrin antagonists in combination with chemotherapeutic agents
304	6,372,712		Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
305	6,372,473		Tissue plasminogen activator-like protease
306	6,372,234		Products for topical applications comprising oil bodies
307	6,369,234		Synthesis of epothilones, intermediates thereto, analogues and uses thereof
308	6,369,109		Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor
309	6,369,096		Benzyloxy prodigiosine compounds
310	6,369,039		High efficiency local drug delivery
311	6,368,788		Method of treating complications in immunodepressed states resulting from HIV infection
312	6,368,658		Coating medical devices using air suspension
313	6,368,613		Use of fluorocarbons for diagnosis and treatment of articular disorders
314	6,365,759		Intermediate compounds for preparing macrocylcic analogs
315	6,365,750		Methods for the preparation of taxanes using oxazolidine intermediates
316	6,365,749		Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
317	6,365,627		Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
318	6,365,577		p53 antisense agent and method
319	6,365,191		Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
320	6,362,321		Taxol resistance associated gene
321	6,362,254		Poly(ethylene glycol) derivatives with proximal reactive groups
322	6,362,217		Taxane anticancer agents
323	6,362,210		Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use
324	6,362,172		Water soluble prodrugs of azole compounds
325	6,359,154		C7 carbamoyloxy substituted taxanes
326	6,359,002		Method for treating a patient with neoplasia by treatment with a platinum coordination complex
327	6,358,996		Stable isotope labeling of paclitaxel
328	6,358,989		Therapeutic inhibitor of vascular smooth muscle cells
329	6,358,985		Inhibitors of prenyl-protein transferase
330	6,358,957		Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
331	6,358,956		Inhibitors of prenyl-protein transferase
332	6,358,557		Graft polymerization of substrate surfaces
333	6,358,508		Antibodies to human tumor necrosis factor receptor TR9
334	6,358,490		Three-step pretargeting methods and compounds
335	6,355,643		Inhibitors of prenyl-protein transferase
336	6,355,628		Combination therapy using pentafluorobenzenesulfonamides
337	6,355,273		Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization
338	6,353,120		Process for the preparation of a paclitaxel C-4 methyl carbonate analog
339	6,351,663		Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
340	6,350,878		Intermediates for the synthesis of epothilones and methods for their preparation
341	6,350,755		Inhibitors of prenyl-protein transferase
342	6,350,464		Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
343	6,350,277		Stents with temporary retaining bands
344	6,348,491		Oil-in-water emulsion for encapsulating paclitaxel
345	6,348,351		Tie receptor tyrosine kinase ligand homologues
346	6,348,337		Process for the preparation of C-4 deacetyltaxanes
347	6,348,215		Stabilization of taxane-containing dispersed systems
348	6,348,209		Formulation and method for treating neoplasms by inhalation
349	6,346,110		Chamber for applying therapeutic substances to an implantable device
350	6,344,571		Water soluble analogs and prodrugs of paclitaxel

351	6,344,324		Quantification of cellular injury using expression of a fluorescent protein under the control of the GADD153 promoter
352	6,344,028		Replenishable stent and delivery system
353	6,344,027		Needle-less injection apparatus and method
354	6,342,520		Locally injectable chemotherapeutics
355	6,342,221		Antibody conjugate compositions for selectively inhibiting VEGF
356	6,342,219		Antibody compositions for selectively inhibiting VEGF
357	6,340,701		Cytotoxic agents comprising taxanes and their therapeutic use
358	6,340,475		Extending the duration of drug release within the stomach during the fed mode
359	6,339,151		Enzyme catalyzed therapeutic agents
360	6,339,142		Protein purification
361	6,338,859		Polymeric micelle compositions
362	6,335,343		Inhibitors of prenyl-protein transferase
363	6,335,029		Polymeric coatings for controlled delivery of active agents
364	6,334,445		Methods and compositions for treatment of ovarian cancer
365	6,333,419		Chromatographic separation method of paclitaxel and cephalomannin
366	6,333,348		Use of docetaxel for treating cancers
367	6,333,347		Intrapericardial delivery of anti-microtubule agents
368	6,333,335		Phenyl-protein transferase inhibitors
369	6,333,333		Methods for treating proliferative diseases
370	6,333,051		Nanogel networks and biological agent compositions thereof
371	6,331,635		Taxoids, their preparation and pharmaceutical compositions containing them
372	6,331,564		Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
373	6,331,285		Structurally determined cyclic metallo-constructs and applications
374	6,331,284		P202 is a tumor suppressor
375	6,329,420		Tubulin binding compounds (COBRA)
376	6,329,376		Inhibitors of prenyl-protein transferase
377	6,329,355		Method for inhibiting the growth of cancers
378	6,326,482		SH2 domain-containing peptides
379	6,323,205		Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors
380	6,323,039		Compositions and methods for assaying subcellular conditions and processes using energy transfer
381	6,322,817		Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
382	6,322,805		Biodegradable polymeric micelle-type drug composition and method for the preparation thereof
383	6,322,797		Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same
384	6,320,045		Process for the reduction of oxiranyl epothilones to olefinic epothilones
385	6,319,943		Oral formulation for paclitaxel
386	6,319,931		Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy
387	6,319,923		Method of treating a tumor
388	6,319,682		Methods and systems for assessing biological materials using optical and spectroscopic detection techniques
389	6,319,230		Lateral needle injection apparatus and method
390	6,316,630		Synthesis of epothilones, intermediates thereto and analogues thereof
391	6,316,522		Bioresorbable hydrogel compositions for implantable prostheses
392	6,316,505		Pharmaceutical compositions comprising fluorinated co-polymers
393	6,316,502		Therapeutic methods employing disulfide derivatives of dithiocarbonates and compositions useful therefor
394	6,316,462		Methods of inducing cancer cell death and tumor regression
395	6,316,436		Inhibitors of prenyl-protein transferase
396	6,313,277		Breast cancer resistance protein (BCRP) and the DNA which encodes it
397	6,313,138		Tyrosine kinase inhibitors
398	6,312,694		Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
399	6,310,039		Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
400	6,308,714		Ultrasound enhanced chemotherapy

No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /